Main > > >MIGRAINE.

---

Prevention. ErenuMAb 70 mg Self-Administered Once Monthly Via Company s
AutoInjector. (U>A)
USA Approval Date: 2018. 05.17.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 05.18.




Prevention: TENS Device.
USA Approval Date: 2014. 03.11.
USA Launch Date : 2017. 11.29.
(*) Company, Patent & TradeMark
Available on Request.
UpDate: 2019. 11.06.




Preventive Treat.: ErenuMAb 70 mg Self-Administered Once Monthly Via Company s
AutoInjector. (U>A)
USA Approval Date: 2018. 05.17.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 05.18.




Preventive Treat.: FremanezuMAb-Vfrm. Inj. (I)
Humanized MAb Binds calcitonin gene-related peptide (CGRP).
EU Approval Date: 2019. 04.01.
USA Approval Date: 2018. 09.14.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 04.02.




Preventive Treat.: GalcanezuMAb-Gnlm Inj. (U>E)
Calcitonin Gene-Related Peptide (CGRP) Antagonist.
CA Approval Date: 2021. 02.25.
USA Approval Date: 2018. 09.27.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2021. 02.26.




TREAT.: Cooling.
Status: Development.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 04.07.




TREAT.: External TNS Device.
USA Launch Date: 2017. 11.29.
(*) Company; Patent & TradeMark
Available on Request.
UpDate: 2017. 11.30.




TREAT.: Non-Invasive Vagal Nerve Stimulation
(nVNS) Device.
USA Clearance Date: 2018. 01.29.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 01.30.




TREAT.: Rimegepant ODT Tablets.
IL Approval Date : 2021. 03.10.
UAE Approval Date: 2021. 03.11.
USA Approval Date: 2020. 02.27.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2021. 04.05.




TREAT.: Sumatriptan Nasal Spray.
USA Approval Date: 2019. 01.28.
(*) Company; Patents; PR Web-Site &
TradeMark Available on Request.
UpDate: 2019. 01.31.





>MIGRAINE.'s products
This section has no products